User profiles for Günter U. Höglinger
Günter HöglingerLudwig-Maximilians-University Hospital, Munich Verified email at dzne.de Cited by 34080 |
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
GU Höglinger, G Respondek, M Stamelou… - Movement …, 2017 - Wiley Online Library
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
GU Höglinger, P Rizk, MP Muriel, C Duyckaerts… - Nature …, 2004 - nature.com
Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine
modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in …
modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in …
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU Höglinger, NM Melhem, DW Dickson… - Nature …, 2011 - nature.com
Progressive supranuclear palsy (PSP) is a movement disorder with prominent tau neuropathology.
Brain diseases with abnormal tau deposits are called tauopathies, the most common …
Brain diseases with abnormal tau deposits are called tauopathies, the most common …
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
GU Höglinger, J Féger, A Prigent… - Journal of …, 2003 - Wiley Online Library
In Parkinson's disease, nigral dopaminergic neurones degenerate, whereas post‐synaptic
striatal target neurones are spared. In some atypical parkinsonian syndromes, both nigral and …
striatal target neurones are spared. In some atypical parkinsonian syndromes, both nigral and …
[HTML][HTML] Distribution patterns of tau pathology in progressive supranuclear palsy
Progressive supranuclear palsy (PSP) is a 4R-tauopathy predominated by subcortical pathology
in neurons, astrocytes, and oligodendroglia associated with various clinical phenotypes…
in neurons, astrocytes, and oligodendroglia associated with various clinical phenotypes…
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical
parkinsonism, is now recognised as a range of motor and behavioural syndromes that are …
parkinsonism, is now recognised as a range of motor and behavioural syndromes that are …
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases
…, T Arzberger, S Wagenpfeil, GU Höglinger… - Movement …, 2014 - Wiley Online Library
… Günter U. Höglinger has served on the advisory boards for Bristol-Myers Squibb, Sellas,
UCB; has received honoraria for scientific presentations from Elan, GlaxoSmithKline, Roche, …
UCB; has received honoraria for scientific presentations from Elan, GlaxoSmithKline, Roche, …
Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors
…, L Decker, D Seilhean, GU Höglinger… - Proceedings of the …, 2007 - National Acad Sciences
In multiple sclerosis (MS), oligodendrocyte and myelin destruction lead to demyelination
with subsequent axonal loss. Experimental demyelination in rodents has highlighted the …
with subsequent axonal loss. Experimental demyelination in rodents has highlighted the …
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases
2-Deoxy-2-[ 18 F]fluoro-d-glucose positron emission tomography (FDG-PET) is widely used
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …
Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease
GU Höglinger, G Carrard, PP Michel… - Journal of …, 2003 - Wiley Online Library
… Address correspondence and reprint requests to Günter U. Höglinger, INSERM U 289,
Experimental Neurology and Therapeutics, Hôpital de la Salpêtrière, 47, Boulevard de l'Hôpital, …
Experimental Neurology and Therapeutics, Hôpital de la Salpêtrière, 47, Boulevard de l'Hôpital, …